Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F John

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Infection Control and Hospital Epidemiology|April 11, 2013
Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unitCassandra D Salgado, Kent A Sepkowitz, Joseph F John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrheaThomas J Louie, Jennifer Peppe, C Kevin Watt, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaJ John Weems, James P Steinberg, Scott Filler, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Guidelines for reporting novel mecA gene homologuesTeruyo Ito, Keiichi Hiramatsu, Alexander Tomasz, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Infection Control and Hospital Epidemiology|April 11, 2013
Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unitCassandra D Salgado, Kent A Sepkowitz, Joseph F John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrheaThomas J Louie, Jennifer Peppe, C Kevin Watt, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaJ John Weems, James P Steinberg, Scott Filler, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Guidelines for reporting novel mecA gene homologuesTeruyo Ito, Keiichi Hiramatsu, Alexander Tomasz, et al.
Pageof 2